This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

State AG News: Robocalls, Healthcare System, Energy Settlement (December 4-11, 2025)

Each week, Crowell & Moring's State Attorneys General team highlights significant actions that State AGs have taken.

United States Healthcare

CM

Crowell & Moring LLP

Bayh-Dole Compliance Requires Your Attention: Best Practices For Universities, Companies, Investors, Strategic Partners, And Acquirors

A significant number of inventions made at academic and research institutions, non-profit research organizations and businesses are developed with federal government funding.

United States Healthcare

FH

Foley Hoag LLP

2025 AI Policy And Health Care Priorities In Review: What Was Hot; What Was Not

2025 saw a sustained increase in health AI policy activity at federal, state, and self-regulatory levels. Across states and in Washington, policymakers...

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

CMS Indefinitely Suspends SNF Ownership Disclosure Deadline

The Centers for Medicare & Medicaid Services (CMS) has issued updated sub-regulatory guidance announcing that the previously established January 1, 2026 deadline...

United States Healthcare

PL

Polsinelli LLP

Understanding The GENEROUS Model In Six Infographics

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

IRS Issues Notice Detailing Expanded Availability Of Health Savings Accounts Under The One Big Beautiful Bill Act (OBBBA)

United States Healthcare

WS

Winston & Strawn LLP

A Penny For Your Thoughts? Understanding The Legal Implications Of The U.S. Penny Shortage (Podcast)

United States Healthcare

HK

Holland & Knight

FDA's TEMPO Pilot Seeks To Expand Access To Chronic Disease Technologies In CMS Collaboration

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

What's Next For Biotech Regulation In 2026

United States Healthcare

OG

Outside GC

FDA In Flux — December 2025 Newsletter

United States Healthcare

M

Mintz

California SB 243: Setting New Standards For Regulating And Ensuring Integrity Of AI Companion Chatbots

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Eleventh Circuit Hears Oral Arguments In High-Profile Challenge To Constitutionality Of The False Claim Act's Qui Tam Provision

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

European Biosimilar Updates – Six Denosumab Launches And Positive Opinion For Samsung Bioepis's BYOOVIZ

United States Healthcare

GP

Goodwin Procter LLP

CMS Finalizes Medicare Payment Policies For Hospital Outpatient And Ambulatory Surgery Center Services

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Healthcare

State AG News: Robocalls, Healthcare System, Energy Settlement (December 4-11, 2025)

Each week, Crowell & Moring's State Attorneys General team highlights significant actions that State AGs have taken.

United States Healthcare

CM

Crowell & Moring LLP

2025 AI Policy And Health Care Priorities In Review: What Was Hot; What Was Not

2025 saw a sustained increase in health AI policy activity at federal, state, and self-regulatory levels. Across states and in Washington, policymakers...

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

CMS Indefinitely Suspends SNF Ownership Disclosure Deadline

The Centers for Medicare & Medicaid Services (CMS) has issued updated sub-regulatory guidance announcing that the previously established January 1, 2026 deadline...

United States Healthcare

PL

Polsinelli LLP

Understanding The GENEROUS Model In Six Infographics

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

IRS Issues Notice Detailing Expanded Availability Of Health Savings Accounts Under The One Big Beautiful Bill Act (OBBBA)

United States Healthcare

WS

Winston & Strawn LLP

A Penny For Your Thoughts? Understanding The Legal Implications Of The U.S. Penny Shortage (Podcast)

United States Healthcare

HK

Holland & Knight

FDA's TEMPO Pilot Seeks To Expand Access To Chronic Disease Technologies In CMS Collaboration

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

What's Next For Biotech Regulation In 2026

United States Healthcare

OG

Outside GC

California SB 243: Setting New Standards For Regulating And Ensuring Integrity Of AI Companion Chatbots

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

See more

Life Sciences, Biotechnology & Nanotechnology

Navigating Bayh-Dole Compliance In 2025: Risks And Risk Mitigation Strategies

A significant number of inventions made at academic and research institutions, non-profit research organizations and businesses are developed using some amount of federal government funding...

United States IP

FH

Foley Hoag LLP

Bayh-Dole Compliance Requires Your Attention: Best Practices For Universities, Companies, Investors, Strategic Partners, And Acquirors

A significant number of inventions made at academic and research institutions, non-profit research organizations and businesses are developed with federal government funding.

United States Healthcare

FH

Foley Hoag LLP

CMS Indefinitely Suspends SNF Ownership Disclosure Deadline

The Centers for Medicare & Medicaid Services (CMS) has issued updated sub-regulatory guidance announcing that the previously established January 1, 2026 deadline...

United States Healthcare

PL

Polsinelli LLP

What's Next For Biotech Regulation In 2026

United States Healthcare

OG

Outside GC

European Biosimilar Updates – Six Denosumab Launches And Positive Opinion For Samsung Bioepis's BYOOVIZ

United States Healthcare

GP

Goodwin Procter LLP

PBMs As De Facto Regulators: A 2025 Recap Of PBM Audits And Their Growing Impact On Board Of Pharmacy Enforcement

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Artificial Intelligence In Clinical Decision-Making: Regulatory Roadmap And Reimbursement Strategies

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

FDA's Support For Onshoring Drug Manufacturing And Increasing Oversight Of Foreign Facilities

United States Healthcare

JD

Jones Day

Return Of The BIOSECURE Act: What Life Sciences Companies Need To Know

United States Healthcare

PL

Polsinelli LLP

See more

Food and Drugs Law

Recent Federal Developments For December 2025

Start 2026 with the information you need — Bergeson & Campbell, P.C. (B&C®), The Acta Group (Acta®), and B&C® Consortia Management, L.L.C. (BCCM)...

United States Energy

BC

Bergeson & Campbell

Understanding The GENEROUS Model In Six Infographics

With the Centers for Medicare & Medicaid Services' (CMS) announcement of the GENEROUS Model, life science companies, states and other stakeholders...

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

IRS Issues Notice Detailing Expanded Availability Of Health Savings Accounts Under The One Big Beautiful Bill Act (OBBBA)

The Internal Revenue Service (the IRS) recently issued Notice 2026-5 which provides guidance on changes to health saving accounts (HSAs) enacted by the One Big Beautiful Bill Act (OBBBA).

United States Healthcare

WS

Winston & Strawn LLP

Media Reports President Trump To Issue Impending Executive Order On Cannabis Rescheduling: Legal Process, Limitations, And Next Steps

United States Cannabis

FH

Foley Hoag LLP

A Penny For Your Thoughts? Understanding The Legal Implications Of The U.S. Penny Shortage (Podcast)

United States Healthcare

HK

Holland & Knight

Compounded GLP-1 Advertising: What Compounders Need To Know NOW

United States Media & IT

BI

Buchanan Ingersoll & Rooney PC

FDA In Flux — December 2025 Newsletter

United States Healthcare

M

Mintz

Eleventh Circuit Hears Oral Arguments In High-Profile Challenge To Constitutionality Of The False Claim Act's Qui Tam Provision

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

The Federal Circuit Raises The Section 112 Stakes For Chemical Structures In Seagen v. Daiichi

United States IP

GP

Goodwin Procter LLP

See more

Latest Videos

See more

When Health Plans Become Health Leaders: Hillary Galyean Rewrites The Health Plan Playbook (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Navigating Food And Dietary Supplements Labeling Litigation & Regulatory Hurdles In 2025 And Beyond (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Upcoming Events

Pestalozzi At The J.P. Morgan Healthcare Conference 2026

United States Healthcare

PL

Pestalozzi Attorneys at Law

Women In Healthcare Private Equity Event

United States Commercial

BB

Bass, Berry & Sims

The Mass League Health Center Compliance Academy: Pharmacy/340B

United States Healthcare

FH

Foley Hoag LLP

The Town Hall Table: From State Chapters To The U.S. Capitol

United States Healthcare

HK

Holland & Knight

2026 Biotech Showcase™ Partnering

United States Healthcare

FH

Foley Hoag LLP

All In The Family - After The Wedding: AMC And Community Hospital Affiliations In Practice - American Health Law Association Academic Medical Centers Conference

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Join Arnold & Porter’s Global Life Sciences Industry Group During The J.P. Morgan Healthcare Conference

United States Healthcare

AP

Arnold & Porter

Life Care Plans: Is It Real Or AI? Ethical Considerations

United States Healthcare

LB

Lewis Brisbois Bisgaard & Smith LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More